{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-001244","form_type":"8-K","ticker":"PRME","cik":"0001894562","company_name":"Prime Medicine, Inc.","filed_at":"2025-01-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.510470+00:00","generated_at":"2026-05-28T03:59:09.196825+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"low","headline":"Prime Medicine posts updated corporate presentation; details not fully disclosed in filing","bullets":["Presentation posted Jan 13, 2025 on company website; included as exhibit but content truncated.","No specific financial or program updates visible in provided filing text.","Presentation titled 'Delivering on the promise of Prime Editing' suggests continued focus on gene editing platform.","Further details may be available on investor relations page."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-001244","json":"https://secwatch.observer/filing/0001628280-25-001244.json","markdown":"https://secwatch.observer/filing/0001628280-25-001244.md","text":"https://secwatch.observer/filing/0001628280-25-001244.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1894562/000162828025001244/0001628280-25-001244-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1894562/000162828025001244/prme-20250113.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T03:59:09.196825+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}